{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:02:44Z","timestamp":1787655764812,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.etap.2022.103907","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:14:39Z","timestamp":1654924479000},"page":"103907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Protective effect of empagliflozin on gentamicin-induced acute renal injury via regulation of SIRT1\/NF-\u03baB signaling pathway"],"prefix":"10.1016","volume":"94","author":[{"given":"Sandy R.","family":"Botros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa I.","family":"Matouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliaa","family":"Anter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.A.","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehan H.","family":"Heeba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.etap.2022.103907_bib1","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3390\/biom11060814","article-title":"The effect of metformin in diabetic and non-diabetic rats with experimentally-induced chronic kidney disease","volume":"11","author":"Al Za\u2019abi","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.etap.2022.103907_bib2","first-page":"53","article-title":"Hematoxylin and eosin","author":"Allen","year":"1992","journal-title":"Lab. Methods Histotechnol."},{"key":"10.1016\/j.etap.2022.103907_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MNH.0b013e32803fb767","article-title":"Toll-like receptors: emerging concepts in kidney disease","volume":"16","author":"Anders","year":"2007","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.etap.2022.103907_bib4","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.etap.2022.103907_bib5","first-page":"384","article-title":"Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axis","volume":"22","author":"Ashrafi Jigheh","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.etap.2022.103907_bib6","article-title":"Resveratrol reduces gentamicin-induced EMT in the kidney via inhibition of reactive oxygen species and involving TGF-\u03b2\/Smad pathway","volume":"258","author":"Beshay","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.etap.2022.103907_bib7","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.1094637","article-title":"Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase","volume":"303","author":"Brunet","year":"2004","journal-title":"science"},{"key":"10.1016\/j.etap.2022.103907_bib8","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/ki.2008.516","article-title":"Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease","author":"Cachofeiro","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.etap.2022.103907_bib9","first-page":"1053","article-title":"Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides","volume":"23","author":"Chen","year":"2009","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.etap.2022.103907_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.medmal.2019.12.003","article-title":"PK\/PD targets of amikacin and gentamicin in ICU patients","volume":"50","author":"Coste","year":"2020","journal-title":"M\u00e9d. Et. Mal. Infect."},{"key":"10.1016\/j.etap.2022.103907_bib11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/AAC.44.3.665-675.2000","article-title":"Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides","volume":"44","author":"El Mouedden","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.etap.2022.103907_bib12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.59566\/IJBS.2013.9082","article-title":"Ameliorative potentials of ginger (Z. officinale Roscoe) on relative organ weights in streptozotocin induced diabetic rats","volume":"9","author":"Eleazu","year":"2013","journal-title":"Int. J. Biomed. Sci.: IJBS"},{"key":"10.1016\/j.etap.2022.103907_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.ackd.2008.04.008","article-title":"Pulmonary complications after acute kidney injury","volume":"15","author":"Faubel","year":"2008","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.etap.2022.103907_bib14","unstructured":"FDA , 2014 .approves Jardiance to treat type 2 diabetes\" [press release]. US Food and Drug Administration 2014."},{"key":"10.1016\/j.etap.2022.103907_bib15","unstructured":"FDA, 2017 . Approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes\" [press release]. US Food and Drug Administration2017."},{"key":"10.1016\/j.etap.2022.103907_bib16","unstructured":"FDA, 2018 . Jardiance prescribing information\" [press release]. US Food and Drug Administration 2018."},{"key":"10.1016\/j.etap.2022.103907_bib17","first-page":"39","article-title":"SIRT1 level differences among old rats, streptozotocin-induced diabetic rats, and D-galactose-induced aging rats","volume":"27","author":"Fidianingsih","year":"2020","journal-title":"Rom. J. Diabetes Nutr. Metab. Dis."},{"key":"10.1016\/j.etap.2022.103907_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.diabres.2013.12.052","article-title":"Genital and urinary tract infections in diabetes: impact of pharmacologically-induced glucosuria","volume":"103","author":"Geerlings","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.etap.2022.103907_bib19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000500093","article-title":"Transforming growth factor-\u03b2 in the acute kidney injury to chronic kidney disease transition","volume":"143","author":"Gewin","year":"2019","journal-title":"Nephron"},{"key":"10.1016\/j.etap.2022.103907_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2011.01517.x","article-title":"Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors","volume":"14","author":"Grempler","year":"2012","journal-title":"Diabetes, Obes. Metab."},{"key":"10.1016\/j.etap.2022.103907_bib21","first-page":"2019","article-title":"Oxidative stress in animal models of acute and chronic renal failure","author":"Gyur\u00e1szov\u00e1","year":"2019","journal-title":"Dis. Markers"},{"key":"10.1016\/j.etap.2022.103907_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbrc.2008.04.176","article-title":"Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression","volume":"372","author":"Hasegawa","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.etap.2022.103907_bib23","doi-asserted-by":"crossref","unstructured":"Hudkins, K.L., Li, X., Holland, A.L., Swaminathan, S., Alpers, C.E., 2021. Regression of diabetic nephropathy by treatment with empagliflozin in BTBR ob\/ob mice. Nephrol Dial Transplant.","DOI":"10.1093\/ndt\/gfab330"},{"key":"10.1016\/j.etap.2022.103907_bib24","article-title":"Sodium-glucose transporter-2 (SGLT2; SLC5A2) enhances cellular uptake of aminoglycosides","volume":"9","author":"Jiang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.etap.2022.103907_bib25","article-title":"Correction: cell atavistic transition: paired box 2 re-expression occurs in mature tubular epithelial cells during acute kidney injury and is regulated by angiotensin II","volume":"10","author":"Jiang","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.etap.2022.103907_bib26","doi-asserted-by":"crossref","first-page":"P140","DOI":"10.1055\/s-0034-1374997","article-title":"Empagliflozin (EMPA) increases genital infections but not urinary tract infections (UTIs) in pooled data from four pivotal phase III trials","volume":"9","author":"Kim","year":"2014","journal-title":"Diabetol. und Stoffwechs."},{"key":"10.1016\/j.etap.2022.103907_bib27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4093\/dmj.2017.0095","article-title":"Effect of empagliflozin, a selective sodium-glucose cotransporter 2 inhibitor, on kidney and peripheral nerves in streptozotocin-induced diabetic rats","volume":"42","author":"Lee","year":"2018","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.etap.2022.103907_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ki.2013.153","article-title":"Raising awareness of acute kidney injury: a global perspective of a silent killer","volume":"84","author":"Lewington","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.etap.2022.103907_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-021-01396-2","article-title":"Renoprotective effect of SGLT-2 inhibitors among type 2 diabetes patients with different baseline kidney function: a multi-center study","volume":"20","author":"Lin","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.etap.2022.103907_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ki.2010.337","article-title":"New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view","volume":"79","author":"Lopez-Novoa","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.etap.2022.103907_bib31","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1089\/ars.2011.4434","article-title":"Redox regulation of p53, redox effectors regulated by p53: a subtle balance","volume":"16","author":"Maillet","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.etap.2022.103907_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.taap.2007.05.004","article-title":"Glomerular nephrotoxicity of aminoglycosides","volume":"223","author":"Martinez-Salgado","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.etap.2022.103907_bib33","doi-asserted-by":"crossref","first-page":"724","DOI":"10.5694\/j.1326-5377.1992.tb121517.x","article-title":"Drug-induced renal disease","volume":"156","author":"Mathew","year":"1992","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.etap.2022.103907_bib34","first-page":"1555","article-title":"Empagliflozin in type 1 diabetes. diabetes, metabolic syndrome and obesity: targets and therapy","volume":"Volume 12","author":"Mathieu","year":"2019"},{"key":"10.1016\/j.etap.2022.103907_bib35","first-page":"687","article-title":"Acute kidney injury: diagnosis and management","volume":"100","author":"Mercado","year":"2019","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.etap.2022.103907_bib36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ki.2010.11","article-title":"Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway","volume":"77","author":"Morales","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.etap.2022.103907_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112394","article-title":"The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity","volume":"9","author":"Oelze","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.etap.2022.103907_bib38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.etap.2022.103907_bib39","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/AAC.01430-08","article-title":"Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units","volume":"53","author":"Oliveira","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.etap.2022.103907_bib40","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1093\/jac\/dkw296","article-title":"Aminoglycoside-associated acute kidney injury in elderly patients with and without shock","volume":"71","author":"Ong","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.etap.2022.103907_bib41","article-title":"Chapter two - Cystatin C: A kidney function biomarker","volume":"57\u201369","author":"Onopiuk","year":"2015"},{"key":"10.1016\/j.etap.2022.103907_bib42","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.etap.2022.103907_bib43","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0959-437X(94)90136-Q","article-title":"The regulation of kidney development: new insights from an old model","volume":"4","author":"Patterson","year":"1994","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.etap.2022.103907_bib44","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/bcp.13216","article-title":"The drugs that mostly frequently induce acute kidney injury: a case\u2212 noncase study of a pharmacovigilance database","volume":"83","author":"Pierson\u2010Marchandise","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2022.103907_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/07853890.2016.1226514","article-title":"Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus: a new perspective on sodium\u2013glucose co-transporter 2 inhibitors","volume":"49","author":"Raheli\u0107","year":"2017","journal-title":"Ann. Med."},{"key":"10.1016\/j.etap.2022.103907_bib46","first-page":"388","article-title":"Gentamicin nephrotoxicity in animals: current knowledge and future perspectives","volume":"16","author":"Randjelovic","year":"2017","journal-title":"Exp. Clin. Sci. J."},{"key":"10.1016\/j.etap.2022.103907_bib47","doi-asserted-by":"crossref","unstructured":"Rob, F., Klubalov\u00e1, B., Ny\u010dov\u00e1, E., Hercogov\u00e1, J., Unemo, M., 2020. Gentamicin 240\u2009mg plus azithromycin 2\u2009g vs. ceftriaxone 500\u2009mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial. Clinical Microbiology and Infection 26, 207\u2013212.","DOI":"10.1016\/j.cmi.2019.08.004"},{"key":"10.1016\/j.etap.2022.103907_bib48","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1172\/JCI200319270","article-title":"Targeted disruption of TGF-beta1\/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. The","volume":"112","author":"Sato","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.etap.2022.103907_bib49","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/sj.ki.5000190","article-title":"Expression of Toll-like receptors in the kidney: their potential role beyond infection","volume":"69","author":"Schroppel","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.etap.2022.103907_bib50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.taap.2004.11.024","article-title":"Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria","volume":"206","author":"Servais","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.etap.2022.103907_bib51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-0270(03)00028-1","article-title":"Quantification of antioxidant activity in brain tissue homogenates using the \u2018total equivalent antioxidant capacity\u2019","volume":"125","author":"Shea","year":"2003","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.etap.2022.103907_bib52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1113\/expphysiol.1997.sp004024","article-title":"Oxidative stress: oxidants and antioxidants","volume":"82","author":"Sies","year":"1997","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.etap.2022.103907_bib53","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.celrep.2013.03.019","article-title":"SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis","volume":"3","author":"Simic","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.etap.2022.103907_bib54","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0022-3565(25)32239-1","article-title":"Inhibitory effects of gentamicin on renal mitochondrial oxidative phosphorylation","volume":"214","author":"Simmons","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.etap.2022.103907_bib55","doi-asserted-by":"crossref","first-page":"100","DOI":"10.21037\/atm.2017.03.06","article-title":"Surgical prophylaxis with gentamicin and acute kidney injury: a systematic review and meta-analysis","volume":"5","author":"Srisung","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.etap.2022.103907_bib56","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jep.2010.08.037","article-title":"Sida rhomboidea.Roxb leaf extract ameliorates gentamicin induced nephrotoxicity and renal dysfunction in rats","volume":"132","author":"Thounaojam","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.etap.2022.103907_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000020498","article-title":"What PAX genes do in the kidney","volume":"6","author":"Torban","year":"1998","journal-title":"Nephron. Exp. Nephrol."},{"key":"10.1016\/j.etap.2022.103907_bib58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.toxrep.2018.11.015","article-title":"Gentamicin induced acute renal damage and its evaluation using urinary biomarkers in rats","volume":"6","author":"Udupa","year":"2019","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.etap.2022.103907_bib59","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","article-title":"hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase","volume":"107","author":"Vaziri","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.etap.2022.103907_bib60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/clpt.1989.4","article-title":"Once-daily dosing decreases renal accumulation of gentamicin and netilmicin","volume":"45","author":"Verpooten","year":"1989","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.etap.2022.103907_bib61","doi-asserted-by":"crossref","first-page":"p97","DOI":"10.1159\/000081558","article-title":"Inhibition of nuclear factor-\u03baB activation attenuates tubulointerstitial nephritis induced by gentamicin","volume":"98","author":"Volpini","year":"2004","journal-title":"Nephron. Physiol."},{"key":"10.1016\/j.etap.2022.103907_bib62","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.etap.2022.103907_bib63","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/dom.14158","article-title":"Consistent effects of empagliflozin on cardiovascular and kidney outcomes irrespective of diabetic kidney disease categories: Insights from the EMPA-REG OUTCOME trial","volume":"22","author":"Wanner","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.etap.2022.103907_bib64","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.etp.2009.03.006","article-title":"Protective effects of Nigella sativa against gentamicin-induced nephrotoxicity in rats","volume":"62","author":"Yaman","year":"2010","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.etap.2022.103907_bib65","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.biopha.2018.10.095","article-title":"Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat","volume":"109","author":"Yang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.etap.2022.103907_bib66","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/CIRCULATIONAHA.120.051685","article-title":"Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: insights from EMPEROR-Reduced","volume":"143","author":"Zannad","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.etap.2022.103907_bib67","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajpath.2016.09.016","article-title":"Sirtuin 1 activation reduces transforming growth factor-\u03b21\u2013induced fibrogenesis and affords organ protection in a model of progressive, experimental kidney and associated cardiac disease","volume":"187","author":"Zhang","year":"2017","journal-title":"Am. J. Pathol."}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668922001004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668922001004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:50:54Z","timestamp":1761299454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668922001004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":67,"alternative-id":["S1382668922001004"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2022.103907","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect of empagliflozin on gentamicin-induced acute renal injury via regulation of SIRT1\/NF-\u03baB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Environmental Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etap.2022.103907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103907"}}